Phantom Farms introduces new Vape Pen for US$3 billion market

View Full News Release

C21 Investments, Inc. (CSE: CXXI) today announced the launch of a new product: the Phantom Vape Pen. The highly anticipated vape pen solves a number of industry challenges by providing uniform viscosity, shelf stability, oil clarity as well as consistency of flavour and potency.

“Vaping is the main driver of concentrate sales, which are projected to reach $8.4 billion in USA sales by 2022,” said Sky Pinnick, Chief Marketing Officer, C21 Investments.  “Our strategy for the Phantom Vape Pen was to provide an affordable, superior product at a highly competitive price point helping to bridge the gap for flower traditionalists to high quality concentrates.”

The Phantom Vape Pen is made by Phantom Farms, a Clean Green Certified cannabis cultivator in Oregon. Using the industry leading CCELL technology with Phantom Farms proprietary terpene-heavy CO2 + distillate extract formulation, the Phantom Vape Pen provides native flavour (terpene) retention, and consistent potency and vaporization experience.

Additionally, the Phantom Vape Pen builds on C21’s strategy to offer wholesale partners a broad offering of vape products at multiple price points and across all C21 CPG’s including Dab Society, Hood Oil and Phantom Farms. The Phantom Vape Pen can be found in dispensaries throughout Oregon and in due course, Nevada.

 

The CSE has not accepted responsibility for the adequacy or accuracy of this release.

Certain statements contained in this news release may constitute forward-looking statements within the meaning of applicable securities legislation. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Forward looking statements in this news release include the unaudited revenue at March 31, 2019, estimated gross margin at March 31, 2019, expected closing of acquisition of Swell companies in April; anticipated timelines for issuance of future revenue reports and the impact of the acquisitions on the Company’s financial information.

The forward-looking statements contained in this news release are based on certain key expectations and assumptions made by C2, including the acquisition of the Swell companies in April and the reliability of the revenue and gross margin at March 31. Although C21 believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because C21 can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the failure to obtain necessary regulatory approvals or satisfy the conditions to closing if the acquisition of the Swell companies in April, C21’s inability to finance and complete the acquisition or, to integrate and expand the acquired businesses as planned, competitive factors in the industries in which C21 operates, prevailing economic and regulatory conditions, and other factors, many of which are beyond the control of C21.

 The forward-looking statements contained in this news release represent C21’s expectations as of the date hereof, and are subject to change after such date. C21 disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required under applicable securities regulations.